RENEF.US Cartesian Growth Corporation II
- Market cap
- USD 79.1M
- P/E
- -
- P/B
- 2.43x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is RENEF.US undervalued?
Graham numberThe Graham number of Cartesian Growth Corporation II cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cartesian Growth Corporation II fundamental analysis
No fundamental analysis for Cartesian Growth Corporation II yet.
Cartesian Growth Corporation II stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cartesian Growth Corporation II
Cartesian Growth Corporation II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
Full company profileCartesian Growth Corporation II financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cartesian Growth Corporation II annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Gross Profit | - | -685K | -2.03M | - | - | - |
| Operating Income | -14.9K | -685K | -2.03M | -1.04M | -931K | -2.11M |
| EBITDA | -3.73K | -2.39M | 11.4M | 8.21M | -931K | -2.11M |
| Net Income | -14.9K | 4.93M | 11.4M | 8.21M | -1.51M | -4.17M |
| EPS | 0.00 | 0.17 | 0.41 | 0.56 | -0.23 | -2.90 |
| Balance Sheet | ||||||
| Total Assets | 464K | 241M | 175M | 85.0M | 38.3M | 6.01M |
| Total Liabilities | 442K | 18.9M | 18.9M | 20.7M | 26.7M | 30.1M |
| Shareholders' Equity | 21.3K | 222M | 156M | 64.3M | -26.3M | -30.0M |
| Cash & Short-term Investments | 0.00 | 544K | 50.9K | 237K | 38.1M | 16.6K |
| Total Debt | 138K | 3.34M | 3.98M | 6.58M | 9.20M | - |
| Cash Flow | ||||||
| Operating Cash Flow | - | -843K | -923K | -814K | -774K | -528K |
| Capital Expenditure | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | -843K | -923K | -814K | -774K | -528K |
| Ratios | ||||||
| ROE | -70.1% | 2.2% | 7.3% | 12.8% | - | - |
| ROA | -3.2% | 2.0% | 6.6% | 9.7% | -4.0% | -69.4% |
| Debt to Equity | 6.51x | 0.02x | 0.03x | 0.10x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cartesian Growth Corporation II dividends
Cartesian Growth Corporation II has not paid dividends in the last 5 fiscal years.
Who owns Cartesian Growth Corporation II
- Insiders 81.12%
- Institutions 18.88%
- Public & others 0.00%
- Shares outstanding 6.23M
- Free float 475K
Cartesian Growth Corporation II company profile
- Company name
- Cartesian Growth Corporation II
- Ticker
- RENEF.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Shell Companies
- Fiscal year end
- December
- Address
- 505 Fifth Avenue, New York, NY, United States, 10017
- Phone
- 212 461 6363
- Website
- cartesiangrowth.com/cgc2
About Cartesian Growth Corporation II
Cartesian Growth Corporation II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
Cartesian Growth Corporation II management
4- Dr. Peter Michael Yu Ph.D.Chairman & CEO · born 1961
- Ms. Beth S. Michelson CFACFO & Director · born 1969
- Mr. Paul Seungpyo Hong Esq., J.D.Senior Managing Director · born 1970
- Mr. Gregory R. ArmstrongSenior Managing Director · born 1978